Skip to content

Long term follow up in patients with intermittent claudication randomized for supervised exercise training or endovascular revascularization

Long term follow up in patients with intermittent claudication randomized for supervised exercise training or endovascular revascularization - CETAC- follow up

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33307
Enrollment
151
Registered
2009-11-17
Start date
2010-03-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intermittent claudication limping

Interventions

None listed

Sponsors

Ikazia Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: As this study is a continuation of the CETAC study the inclusion criteria have been described extensively in the CETAC study.

Exclusion criteria

Exclusion criteria: As this study is a continuation of the CETAC study the exclusion criteria have been described extensively in the CETAC study.

Design outcomes

Primary

MeasureTime frame
maximum walking distance

Secondary

MeasureTime frame
preference based utilities (EQ-5Dand Rating Scale), health status QoL scores (SF-36 and VascuQol), ankle-brachial index, maximum painless walking distance, clinical success, risk factor score, number of events, patency rates

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)